GlassScriptPhysician profile
Susanne A Richards
NPI 1992733216
$1,692.03
in general payments reported to CMS, 2019-2025
20 companies · $397 in 2025
The $397 reported for 2025 was more than what 81% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $565 · 2022: $36.29 · 2023: $400 · 2024: $294 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $255.23 | 2021 | |
| Abbvie INC. | $251.02 | 2021-2025 | |
| Astellas Pharma US INC | $202.11 | 2023-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $179.75 | 2021-2025 | Phexxi, Solosec, Phexx |
| Sage Therapeutics, LLC | $147.29 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $110.01 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $103.23 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.53 | 2021-2024 | |
| Shield Therapeutics INC | $44.66 | 2024 | |
| Organon LLC | $40.49 | 2023 | Nexplanon |
| Avion Pharmaceuticals | $37.17 | 2021-2023 | Balcoltra |
| Hologic Sales and Service, LLC | $37.17 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Agile Therapeutics, INC. | $34.94 | 2021 | |
| Exeltis, USA INC. | $33.51 | 2021-2025 | Slynd |
| Myovant Sciences INC. | $33.49 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $24.46 | 2021 | |
| Supernus Pharmaceuticals, INC. | $24.02 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $23.44 | 2021 | |
| Coopersurgical, INC. | $22.62 | 2025 | Paragard T 380a |
| Exact Sciences Corporation | $12.89 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susanne Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.